Europe Pharmaceutical Intermediates Market to Grow at a CAGR of 3.6% to reach US$ 10,135.51 million Million from 2021 to 2028

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Europe Pharmaceutical Intermediates Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Europe Pharmaceutical Intermediates Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Growing demand for generic drugs and biosimilars
5.1.2 Rising healthcare needs globally, especially in emerging markets

5.2 Market Opportunities

5.2.1 Expansion in the production of active pharmaceutical ingredients (APIs)
5.2.2 Growth in contract manufacturing services

5.3 Future Trends

5.3.1 Increased focus on sustainable and cost-effective production processes
5.3.2 Advancements in synthetic biology for drug development

5.4 Impact of Drivers and Restraints

6. Europe Pharmaceutical Intermediates Market Regional Analysis

6.1 Europe Pharmaceutical Intermediates Market Overview

6.2 Europe Pharmaceutical Intermediates Market Revenue 2019-2028 (US$ Million)

6.3 Europe Pharmaceutical Intermediates Market Forecast Analysis

7. Europe Pharmaceutical Intermediates Market Analysis – by Type

7.1 GMP

7.1.1 Overview
7.1.2 GMP: Europe Pharmaceutical Intermediates Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Non GMP

7.2.1 Overview
7.2.2 Non GMP: Europe Pharmaceutical Intermediates Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Pharmaceutical Intermediates Market Analysis – by Application

8.1 Antibiotics

8.1.1 Overview
8.1.2 Antibiotics: Europe Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (US$ Million)

8.2 Antipyretic Analgesics

8.2.1 Overview
8.2.2 Antipyretic Analgesics: Europe Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (US$ Million)

8.3 Vitamins

8.3.1 Overview
8.3.2 Vitamins: Europe Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (US$ Million)

9. Europe Pharmaceutical Intermediates Market Analysis – by Distribution Channel

9.1 Distributor

9.1.1 Overview
9.1.2 Vitamins: Europe Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (US$ Million)

9.2 Direct Sales

9.2.1 Overview
9.2.2 Vitamins: Europe Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (US$ Million)

10. Europe Pharmaceutical Intermediates Market – Europe Analysis

10.1 Europe

10.1.1 Europe Pharmaceutical Intermediates Market Breakdown, by Key Country, 2022 and 2028 (%)
10.1.1.1 Europe Pharmaceutical Intermediates Market – Revenue and Forecast Analysis – by Country
10.1.1.1 UK: Europe Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1 UK: Europe Pharmaceutical Intermediates Market Breakdown, by Type
10.1.1.1.2 UK: Europe Pharmaceutical Intermediates Market Breakdown, by Application
10.1.1.1.3 UK: Europe Pharmaceutical Intermediates Market Breakdown, by Distribution Channel

10.1.1.2 Germany: Europe Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1 Germany: Europe Pharmaceutical Intermediates Market Breakdown, by Type
10.1.1.2.2 Germany: Europe Pharmaceutical Intermediates Market Breakdown, by Application
10.1.1.2.3 Germany: Europe Pharmaceutical Intermediates Market Breakdown, by Distribution Channel

10.1.1.3 France: Europe Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1 France: Europe Pharmaceutical Intermediates Market Breakdown, by Type
10.1.1.3.2 France: Europe Pharmaceutical Intermediates Market Breakdown, by Application
10.1.1.3.3 France: Europe Pharmaceutical Intermediates Market Breakdown, by Distribution Channel

10.1.1.4 Russia: Europe Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.1 Russia: Europe Pharmaceutical Intermediates Market Breakdown, by Type
10.1.1.4.2 Russia: Europe Pharmaceutical Intermediates Market Breakdown, by Application
10.1.1.4.3 Russia: Europe Pharmaceutical Intermediates Market Breakdown, by Distribution Channel

10.1.1.5 Italy: Europe Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.1 Italy: Europe Pharmaceutical Intermediates Market Breakdown, by Type
10.1.1.5.2 Italy: Europe Pharmaceutical Intermediates Market Breakdown, by Application
10.1.1.5.3 Italy: Europe Pharmaceutical Intermediates Market Breakdown, by Distribution Channel

10.1.1.6 Rest of Europe: Europe Pharmaceutical Intermediates Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.1 Rest of Europe: Europe Pharmaceutical Intermediates Market Breakdown, by Type
10.1.1.6.2 Rest of Europe: Europe Pharmaceutical Intermediates Market Breakdown, by Application
10.1.1.6.3 Rest of Europe: Europe Pharmaceutical Intermediates Market Breakdown, by Distribution Channel

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Europe Pharmaceutical Intermediates Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 BASF SE

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 chiracon GmbH

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Codexis

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Dextra Laboratories Limited

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Dishman Carbogen Amcis Ltd

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Midas Pharma GmbH

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Pfizer Inc.

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Sanofi

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

14. Appendix

14.1 About Business Market Insights